Canada Pension Plan Investment Board’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,116,966
| Closed | -$66.5M | – | 1459 |
|
|
2024
Q1 | $66.5M | Hold |
3,116,966
| – | – | 0.07% | 255 |
|
|
2023
Q4 | $30M | Hold |
3,116,966
| – | – | 0.04% | 336 |
|
|
2023
Q3 | $8.1M | Hold |
3,116,966
| – | – | 0.01% | 521 |
|
|
2023
Q2 | $14.6M | Hold |
3,116,966
| – | – | 0.02% | 424 |
|
|
2023
Q1 | $11.8M | Hold |
3,116,966
| – | – | 0.02% | 433 |
|
|
2022
Q4 | $9.82M | Hold |
3,116,966
| – | – | 0.02% | 414 |
|
|
2022
Q3 | $9.38M | Hold |
3,116,966
| – | – | 0.02% | 438 |
|
|
2022
Q2 | $7.76M | Hold |
3,116,966
| – | – | 0.01% | 468 |
|
|
2022
Q1 | $24.2M | Hold |
3,116,966
| – | – | 0.03% | 365 |
|
|
2021
Q4 | $13M | Hold |
3,116,966
| – | – | 0.01% | 518 |
|
|
2021
Q3 | $24.7M | Hold |
3,116,966
| – | – | 0.03% | 422 |
|
|
2021
Q2 | $25.2M | Hold |
3,116,966
| – | – | 0.03% | 396 |
|
|
2021
Q1 | $33.4M | Hold |
3,116,966
| – | – | 0.04% | 333 |
|
|
2020
Q4 | $36.6M | Hold |
3,116,966
| – | – | 0.05% | 269 |
|
|
2020
Q3 | $37.5M | Hold |
3,116,966
| – | – | 0.07% | 186 |
|
|
2020
Q2 | $54.5M | Buy |
+3,116,966
| New | +$54.3M | 0.12% | 131 |
|
Canada Pension Plan Investment Board's FUSN Position: Q2 2024 in Review
Canada Pension Plan Investment Board sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 3,116,966 shares — an estimated $66.5M sold.
Canada Pension Plan Investment Board first reported a position in FUSN in Q2 2020 and held it in 16 quarters. The position peaked at $66.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.
- Canada Pension Plan Investment Board reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
- Canada Pension Plan Investment Board sold 3,116,966 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $66.5M.
- Canada Pension Plan Investment Board first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 16 quarters.
- Canada Pension Plan Investment Board's Fusion Pharmaceuticals Inc. Common Shares position peaked at $66.5M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2024, filed 12 Aug 2024.